克隆-话题@MedSci

#克隆#

209篇内容 | 3862人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1660263, encodeId=0fc9166026320, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=靶向IL-4R单克隆抗体 (AK120) 治疗特应性皮炎和哮喘，中国II期临床试验已经启动, objectType=article, longId=218737, objectId=eb23218e37f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb23218e37f3, replyNumber=0, likeNumber=109, createdTime=2022-08-02, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb23218e37f3, moduleTitle=靶向IL-4R单克隆抗体 (AK120) 治疗特应性皮炎和哮喘，中国II期临床试验已经启动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb23218e37f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660251, encodeId=9f82166025163, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Blood：急性髓系白血病FLT3-ITD突变的克隆进化, objectType=article, longId=212621, objectId=5d5021262130, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d5021262130, replyNumber=0, likeNumber=78, createdTime=2021-09-20, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d5021262130, moduleTitle=Blood：急性髓系白血病FLT3-ITD突变的克隆进化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d5021262130)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660257, encodeId=a8aa166025ed5, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Cell Discovery：中国团队发现针对德尔塔变异株有效单克隆抗体, objectType=article, longId=215830, objectId=d72e215830fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d72e215830fe, replyNumber=0, likeNumber=88, createdTime=2022-05-20, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d72e215830fe, moduleTitle=Cell Discovery：中国团队发现针对德尔塔变异株有效单克隆抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d72e215830fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660272, encodeId=60bc16602e2bc, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=LEUKEMIA：克隆性骨髓生成易导致慢性肾病的不良结局, objectType=article, longId=292955, objectId=e2122929559e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2122929559e, replyNumber=0, likeNumber=50, createdTime=2022-02-01, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2122929559e, moduleTitle=LEUKEMIA：克隆性骨髓生成易导致慢性肾病的不良结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2122929559e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660262, encodeId=24a31660262e4, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=HAEMATOLOGICA：伊布替尼治疗不能诱导慢性淋巴细胞白血病的TP53克隆进化, objectType=article, longId=218715, objectId=800e218e15c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=800e218e15c8, replyNumber=0, likeNumber=75, createdTime=2022-08-22, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=800e218e15c8, moduleTitle=HAEMATOLOGICA：伊布替尼治疗不能诱导慢性淋巴细胞白血病的TP53克隆进化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=800e218e15c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660255, encodeId=d7b916602554c, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Celltrion的新冠肺炎单克隆抗体治疗药物瑞丹维单抗对德尔塔变异株显示出强效中和活性, objectType=article, longId=214479, objectId=3d532144e904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d532144e904, replyNumber=0, likeNumber=60, createdTime=2021-08-21, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d532144e904, moduleTitle=Celltrion的新冠肺炎单克隆抗体治疗药物瑞丹维单抗对德尔塔变异株显示出强效中和活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d532144e904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660267, encodeId=5070166026e7e, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Celltrion的单克隆抗体药物瑞丹维单抗获欧盟委员会批准用于治疗新冠肺炎, objectType=article, longId=220524, objectId=62c1220524a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62c1220524a2, replyNumber=0, likeNumber=81, createdTime=2022-10-12, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62c1220524a2, moduleTitle=Celltrion的单克隆抗体药物瑞丹维单抗获欧盟委员会批准用于治疗新冠肺炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62c1220524a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660260, encodeId=2383166026035, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=ARD：新白细胞介素6单克隆抗体Olokizuma与甲氨蝶呤联合用于甲氨蝶呤单药控制不佳的类风湿性关节炎患者：随机对照III期研究评估有效性和安全性的结果, objectType=article, longId=217391, objectId=c97e21e39180, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c97e21e39180, replyNumber=0, likeNumber=0, createdTime=2022-04-25, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c97e21e39180, moduleTitle=ARD：新白细胞介素6单克隆抗体Olokizuma与甲氨蝶呤联合用于甲氨蝶呤单药控制不佳的类风湿性关节炎患者：随机对照III期研究评估有效性和安全性的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c97e21e39180)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660253, encodeId=a4d6166025360, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=JAMA Cardiol：不健康的饮食可加速克隆性造血以及不良心血管事件发生发展, objectType=article, longId=213746, objectId=3423213e4624, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3423213e4624, replyNumber=0, likeNumber=62, createdTime=2021-11-14, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3423213e4624, moduleTitle=JAMA Cardiol：不健康的饮食可加速克隆性造血以及不良心血管事件发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3423213e4624)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660249, encodeId=be421660249dc, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=JACC：克隆性造血与左心室射血分数降低的心衰进展风险的相关性, objectType=article, longId=209941, objectId=72a420994178, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72a420994178, replyNumber=0, likeNumber=63, createdTime=2021-05-15, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72a420994178, moduleTitle=JACC：克隆性造血与左心室射血分数降低的心衰进展风险的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72a420994178)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660261, encodeId=6c93166026118, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Clin Cancer Res：抗集落刺激因子单克隆抗体Lacnotuzumab联合吉西他滨-卡铂治疗三阴性乳腺癌的疗效, objectType=article, longId=218488, objectId=28cf21848858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28cf21848858, replyNumber=0, likeNumber=79, createdTime=2022-04-23, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28cf21848858, moduleTitle=Clin Cancer Res：抗集落刺激因子单克隆抗体Lacnotuzumab联合吉西他滨-卡铂治疗三阴性乳腺癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28cf21848858)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660245, encodeId=2524166024562, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=随着COVID-19变体的传播，FDA决定限制礼来单克隆抗体治疗, objectType=article, longId=208698, objectId=3d242086983d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d242086983d, replyNumber=0, likeNumber=0, createdTime=2022-02-26, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d242086983d, moduleTitle=随着COVID-19变体的传播，FDA决定限制礼来单克隆抗体治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d242086983d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660243, encodeId=cf381660243b2, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=抗MERS冠状病毒的单克隆抗体在I期试验中显示出希望, objectType=article, longId=207568, objectId=639420e5682d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=639420e5682d, replyNumber=0, likeNumber=66, createdTime=2021-11-15, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=639420e5682d, moduleTitle=抗MERS冠状病毒的单克隆抗体在I期试验中显示出希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=639420e5682d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660271, encodeId=dbd916602e124, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle= Lancet Respir Med：单克隆抗体adrecizumab对急性心源性休克患者的疗效, objectType=article, longId=291950, objectId=6a9b291950c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a9b291950c4, replyNumber=0, likeNumber=95, createdTime=2022-05-10, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a9b291950c4, moduleTitle= Lancet Respir Med：单克隆抗体adrecizumab对急性心源性休克患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a9b291950c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660241, encodeId=33e61660241cd, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Circulation：早绝经是克隆性造血和冠脉疾病的独立风险因素！, objectType=article, longId=206682, objectId=2bd0206682a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bd0206682a3, replyNumber=0, likeNumber=73, createdTime=2021-12-17, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bd0206682a3, moduleTitle=Circulation：早绝经是克隆性造血和冠脉疾病的独立风险因素！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bd0206682a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660256, encodeId=82c61660256d6, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=NEJM：长效单克隆抗体CIS43LS用于疟疾的预防, objectType=article, longId=215677, objectId=77c82156e78d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77c82156e78d, replyNumber=0, likeNumber=103, createdTime=2021-09-11, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77c82156e78d, moduleTitle=NEJM：长效单克隆抗体CIS43LS用于疟疾的预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77c82156e78d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660270, encodeId=a5cc16602e032, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Leukemia： JAK2 和 ERK 的双重靶向干扰骨髓增殖性肿瘤克隆并提高治疗效果, objectType=article, longId=292080, objectId=dec9292080e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dec9292080e9, replyNumber=0, likeNumber=113, createdTime=2022-02-24, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dec9292080e9, moduleTitle=Leukemia： JAK2 和 ERK 的双重靶向干扰骨髓增殖性肿瘤克隆并提高治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dec9292080e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660240, encodeId=b92e1660240a5, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=单克隆抗体或可预防艾滋病毒感染，去年受关注百篇论文公布 | 一周科技导报, objectType=article, longId=206588, objectId=e16920658865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e16920658865, replyNumber=0, likeNumber=91, createdTime=2021-11-06, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e16920658865, moduleTitle=单克隆抗体或可预防艾滋病毒感染，去年受关注百篇论文公布 | 一周科技导报, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e16920658865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660259, encodeId=0a2316602593e, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=腾盛博药单克隆抗体联合疗法使住院和死亡复合终点降低78%, objectType=article, longId=216340, objectId=d3282163405f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3282163405f, replyNumber=0, likeNumber=90, createdTime=2022-02-04, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3282163405f, moduleTitle=腾盛博药单克隆抗体联合疗法使住院和死亡复合终点降低78%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3282163405f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660246, encodeId=eab016602460f, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Nat Commun：恶性胸膜间皮瘤的克隆结构可作为预后指标并影响肿瘤微环境, objectType=article, longId=208935, objectId=ef2720893512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef2720893512, replyNumber=0, likeNumber=74, createdTime=2021-08-30, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef2720893512, moduleTitle=Nat Commun：恶性胸膜间皮瘤的克隆结构可作为预后指标并影响肿瘤微环境, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef2720893512)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

克隆

2020-05-29

aids221 (审核中...)

前往app查看评论内容

#克隆#

靶向IL-4R单克隆抗体 (AK120) 治疗特应性皮炎和哮喘，中国II期临床试验已经启动

2022-08-02

aids221 (审核中...)

前往app查看评论内容

#克隆#

Blood：急性髓系白血病FLT3-ITD突变的克隆进化

2021-09-20

aids221 (审核中...)

前往app查看评论内容

#克隆#

Cell Discovery：中国团队发现针对德尔塔变异株有效单克隆抗体

2022-05-20

aids221 (审核中...)

前往app查看评论内容

#克隆#

LEUKEMIA：克隆性骨髓生成易导致慢性肾病的不良结局

2022-02-01

aids221 (审核中...)

前往app查看评论内容

#克隆#

HAEMATOLOGICA：伊布替尼治疗不能诱导慢性淋巴细胞白血病的TP53克隆进化

2022-08-22

aids221 (审核中...)

前往app查看评论内容

#克隆#

Celltrion的新冠肺炎单克隆抗体治疗药物瑞丹维单抗对德尔塔变异株显示出强效中和活性

2021-08-21

aids221 (审核中...)

前往app查看评论内容

#克隆#

Celltrion的单克隆抗体药物瑞丹维单抗获欧盟委员会批准用于治疗新冠肺炎

2022-10-12

aids221 (审核中...)

前往app查看评论内容

#克隆#

ARD：新白细胞介素6单克隆抗体Olokizuma与甲氨蝶呤联合用于甲氨蝶呤单药控制不佳的类风湿性关节炎患者：随机对照III期研究评估有效性和安全性的结果

2022-04-25

aids221 (审核中...)

前往app查看评论内容

#克隆#

JAMA Cardiol：不健康的饮食可加速克隆性造血以及不良心血管事件发生发展

2021-11-14

aids221 (审核中...)

前往app查看评论内容

#克隆#

JACC：克隆性造血与左心室射血分数降低的心衰进展风险的相关性

2021-05-15

aids221 (审核中...)

前往app查看评论内容

#克隆#

Clin Cancer Res：抗集落刺激因子单克隆抗体Lacnotuzumab联合吉西他滨-卡铂治疗三阴性乳腺癌的疗效

2022-04-23

aids221 (审核中...)

前往app查看评论内容

#克隆#

随着COVID-19变体的传播，FDA决定限制礼来单克隆抗体治疗

2022-02-26

aids221 (审核中...)

前往app查看评论内容

#克隆#

抗MERS冠状病毒的单克隆抗体在I期试验中显示出希望

2021-11-15

aids221 (审核中...)

前往app查看评论内容

#克隆#

Lancet Respir Med：单克隆抗体adrecizumab对急性心源性休克患者的疗效

2022-05-10

aids221 (审核中...)

前往app查看评论内容

#克隆#

Circulation：早绝经是克隆性造血和冠脉疾病的独立风险因素！

2021-12-17

aids221 (审核中...)

前往app查看评论内容

#克隆#

NEJM：长效单克隆抗体CIS43LS用于疟疾的预防

2021-09-11

aids221 (审核中...)

前往app查看评论内容

#克隆#

Leukemia： JAK2 和 ERK 的双重靶向干扰骨髓增殖性肿瘤克隆并提高治疗效果

2022-02-24

aids221 (审核中...)

前往app查看评论内容

#克隆#

单克隆抗体或可预防艾滋病毒感染，去年受关注百篇论文公布 | 一周科技导报

2021-11-06

aids221 (审核中...)

前往app查看评论内容

#克隆#

腾盛博药单克隆抗体联合疗法使住院和死亡复合终点降低78%

2022-02-04

aids221 (审核中...)

前往app查看评论内容

#克隆#

Nat Commun：恶性胸膜间皮瘤的克隆结构可作为预后指标并影响肿瘤微环境

2021-08-30

科室
- - 订阅+
  - 更多科室
工具
服务